Radiation following percutaneous balloon aortic valvuloplasty to prevent restenosis (RADAR pilot trial)

Objectives: We wished to determine the feasibility and early safety of external beam radiation therapy (EBRT) used following balloon aortic valvuloplasty (BAV) to prevent restenosis. Background: BAV for calcific aortic stenosis (AS) has been largely abandoned because of high restenosis rates, i.e., > 80% at 1 year. Radiation therapy is useful in preventing restenosis following vascular interventions and treating other benign noncardiovascular disorders. Methods: We conducted a 20‐patient, pilot study evaluating EBRT to prevent restenosis following BAV in elderly patients with calcific AS. Total doses ranging from 12–18 Gy were delivered in fractions over a 3–5 day post‐op period to the aortic valve. Echocardiography was performed pre and 2 days post‐op, 1, 6, and 12 months following BAV. Results: One‐year follow‐up is completed (age 89 ± 4). There were no complications related to EBRT. Eight patients died prior to 1 year; 5 of 10 (50%) in the low‐dose (12 Gy) group and 3 of 10 (30%) in the high‐dose (15–18 Gy) group. None of these 8 patients had restenosis, i.e., > 50% loss of the initial AVA gain, and only three deaths were cardiac in origin. One patient underwent aortic valve replacement and none repeated BAV. By 1 year, 3 of the initial 10 (30%) in the low‐dose group and 1 of 9 (11%) in the high‐dose group demonstrated restenosis (21% overall). Conclusions: EBRT following BAV in elderly patients with AS is feasible, free of early complications, and holds promise in reducing the 1 year restenosis rate in a dose‐dependent fashion. © 2006 Wiley‐Liss, Inc.

[1]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[2]  M. Schemper,et al.  Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.

[3]  C. Pepine,et al.  Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.

[4]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[5]  M. Enriquez-Sarano,et al.  Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. , 2002, Journal of the American College of Cardiology.

[6]  C. Otto,et al.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[8]  A. Soni,et al.  The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. , 1999, Seminars in radiation oncology.

[9]  T. Lo.  Radiation therapy for heterotopic ossification. , 1999, Seminars in radiation oncology.

[10]  G. Noël,et al.  [Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy]. , 1998, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[11]  K S Pieper,et al.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. , 1995, Journal of the American College of Cardiology.

[12]  F. Anselme,et al.  Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. , 1995, European heart journal.

[13]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[14]  S. Rahimtoola.  Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. , 1994, Journal of the American College of Cardiology.

[15]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[16]  J. Carroll,et al.  Restenosis following successful balloon valvuloplasty: bone formation in aortic valve leaflets. , 1993, Catheterization and cardiovascular diagnosis.

[17]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[18]  P. Serruys,et al.  Histological changes in the aortic valve after balloon dilatation: evidence for a delayed healing process. , 1992, British heart journal.

[19]  L. Wilkins.  Percutaneous Balloon Aortic Valvuloplasty: Acute and 30‐Day Follow‐up Results in 674 Patients From the NHLBI Balloon Valvuloplasty Registry , 1991, Circulation.

[20]  H. Just,et al.  Clinical and Doppler echocardiographic follow-up after percutaneous balloon valvuloplasty for aortic valve stenosis. , 1991, The American journal of cardiology.

[21]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  D. Holmes,et al.  Doppler evaluation of results of percutaneous aortic balloon valvuloplasty in calcific aortic stenosis. , 1988, Circulation.

[23]  S. Gottlieb,et al.  Double vs single balloon technique for aortic balloon valvuloplasty. , 1988, Chest.

[24]  N C Nanda,et al.  Evaluation of aortic insufficiency by Doppler color flow mapping. , 1987, Journal of the American College of Cardiology.

[25]  G. Hutchins,et al.  Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. , 1987, Journal of the American College of Cardiology.

[26]  S. Schnitt,et al.  Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. , 1986, Circulation.

[27]  J. Gillooley,et al.  Treatment of keloids by combined surgical excision and immediate postoperative X-ray therapy. , 1982, Annals of plastic surgery.

[28]  W. O’Neill.  Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. , 1991, Journal of the American College of Cardiology.

[29]  S. F. Stanley E. Order MD,et al.  Radiation Therapy of Benign Diseases , 1990, Medical Radiology.

[30]  J. R. Stewart.  Normal tissue tolerance to irradiation of the cardiovascular system. , 1989, Frontiers of radiation therapy and oncology.

[31]  H. Hammar,et al.  Treatment of keloids with excision and postoperative X-ray irradiation. , 1983, Dermatologica.

[32]  R GORLIN,et al.  Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. , 1951, American heart journal.